Verition Fund Management
AGIO icon

Verition Fund Management’s Agios Pharmaceuticals AGIO Stock Holding History

Verition Fund Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-27,753
Closed -$813K – 3610
2025
Q1 		$813K Sell
27,753
-19,072
-41% -$633K ﹤0.01% 2272
2024
Q4 		$1.54M Buy
46,825
+39,728
+560% +$1.87M 0.01% 1735
2024
Q3 		$315K Buy
+7,097
New +$322K ﹤0.01% 2608
2020
Q4 		– Sell
-6,936
Closed -$243K – 1072
2020
Q3 		$243K Buy
+6,936
New +$304K ﹤0.01% 867
2020
Q1 		– Sell
-4,828
Closed -$231K – 575
2019
Q4 		$231K Sell
4,828
-1,754
-27% -$66.3K ﹤0.01% 912
2019
Q3 		$213K Buy
+6,582
New +$272K 0.01% 934
2019
Q2 		– Sell
-9,075
Closed -$612K – 1041
2019
Q1 		$612K Buy
+9,075
New +$529K 0.02% 579
2018
Q2 		– Sell
-8,228
Closed -$673K – 1051
2018
Q1 		$673K Buy
+8,228
New +$636K 0.05% 521
2017
Q4 		– Sell
-7,851
Closed -$524K – 856
2017
Q3 		$524K Buy
+7,851
New +$472K 0.04% 552
2017
Q2 		– Sell
-10,189
Closed -$595K – 897
2017
Q1 		$595K Buy
+10,189
New +$488K 0.06% 474
2015
Q3 		– Sell
-5,895
Closed -$655K – 501
2015
Q2 		$655K Buy
+5,895
New +$635K 0.11% 139

Other funds holding AGIO

FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Verition Fund Management's AGIO Position: Q2 2025 in Review

Verition Fund Management sold out of Agios Pharmaceuticals (AGIO) in Q2 2025, closing a stake of 27,753 shares — an estimated $813K sold.

Verition Fund Management first reported a position in AGIO in Q2 2015 and held it in 11 quarters. The position peaked at $1.54M in Q4 2024. 215 funds tracked by Wall St. Rank hold AGIO as of Q2 2025.

  • Verition Fund Management reported no remaining Agios Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Verition Fund Management sold 27,753 Agios Pharmaceuticals shares in Q2 2025, an estimated $813K.
  • Verition Fund Management first reported a position in Agios Pharmaceuticals in Q2 2015 and held it in 11 quarters.
  • Verition Fund Management's Agios Pharmaceuticals position peaked at $1.54M in Q4 2024.
  • 215 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2025.

Based on Verition Fund Management's 13F filing for Q2 2025, filed 14 Aug 2025.